Interactions between environmental stimulation and antipsychotic drug effects on forebrain c-Fos activation

Neuroscience

Volumn 104, Issue 3, 2001, Pages 717-730

  Murphy, C A ^a   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Clozapine; Fos; Haloperidol; Prefrontal cortex; Stress; Striatum

Indexed keywords

BRAIN PROTEIN; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PROTEIN FOS;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FOREBRAIN; GENE ACTIVATION; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SCHIZOPHRENIA; STIMULUS RESPONSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CELL COUNT; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT, CONTROLLED; HALOPERIDOL; IMMUNOHISTOCHEMISTRY; MALE; MOTOR ACTIVITY; NEURONS; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR;

EID: 0035859191     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00110-5     Document Type: Article

References (61)

1. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: Modulation by environmental novelty
2. Clozapine: A novel antipsychotic agent
3. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli
4. Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex
5. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients
6. Schizophrenia and psychosocial stresses
7. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam pretreatment
8. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: Implications for screening new antipsychotic drugs
9. Clozapine: An atypical neuroleptic
10. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia
11. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia
12. Activation of midline thalamic nuclei by antipsychotic drugs
13. Differential effects of acute administration of clozapine or HAL on local cerebral glucose utilization in the rat
14. Pattern and time course of immediate-early gene expression in rat brain following acute stress
15. Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression
16. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell
17. The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization
18. Antipsychotic drugs induce fos protein in the thalamic paraventricular nucleus: A novel locus of antipsychotic drug action
19. Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat
20. Topographic patterns of brain activity in response to swim stress: Assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity
21. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety
22. Functional classification of antidepressants based on antagonism of swim stress-induced Fos-like immunoreactivity
23. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation
24. Differential forebrain c-fos mRNA by ether inhalation and novelty: Evidence for distinctive stress pathways
25. Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain
26. The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of a1-adrenergic or 5HT2 receptor blockade to haloperidol
27. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs
28. Basic biology of clozapine: Electrophysiological and neuroendocrinological studies
29. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain
30. Induction of c-fos mRNA in the brain and anterior pituitary gland by a novel environment
31. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core
32. Limbic-prefrontal connectivity and clozapine
33. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems
34. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons
35. Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses
36. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja
37. Distribution of effects of haloperidol on energy metabolism in the rat brain
38. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: Role of dopamine D2 and D3 receptors
39. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance
40. The behavioral pharmacology of typical and atypical antipsychotic drugs
41. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile
42. Selective increase of a1-adrenoceptors and muscarinic cholinergic receptors in rat cerebral cortex after chronic haloperidol
43. Reduced metabolic response of the rat brain to haloperidol after chronic treatment
44. Comparative effects of short- and long-term treatment with neuroleptics on behavioural activity as well as dopamine turnover in striatum
45. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty
46. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
47. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
48. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss
49. Stress and the mesocorticolimbic dopamine systems
50. The effects of clozapine on shuttle-box avoidance responding in rats: Comparisons with haloperidol and chlordiazepoxide
51. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
52. Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment
53. Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions
54. Olanzapine-induced Fos expression in the rat forebrain; cross tolerance with haloperidol and clozapine
55. Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, nucleus accumbens and lateral septum after typical and atypical antipsychotics: An in situ hybridization study
56. Quinpirole attenuates the striatal Fos expression induced by escape behavior
57. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex
58. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics
59. Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: A regionally-specific double dissociation
60. Reversal by L-DOPA of impaired learning due to destruction of the dopaminergic nigro-neostriatal projection